LCM
Lakewood Capital Management’s Charles River Laboratories CRL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $21.3M | Hold |
140,240
| – | – | 1.59% | 23 |
|
|
2025
Q1 | $21.1M | Buy |
140,240
+28,500
| +26% | +$4.29M | 1.84% | 20 |
|
|
2024
Q4 | $20.6M | Hold |
111,740
| – | – | 1.85% | 20 |
|
|
2024
Q3 | $22M | Hold |
111,740
| – | – | 1.73% | 21 |
|
|
2024
Q2 | $23.1M | Sell |
111,740
-1,000
| -0.9% | -$207K | 1.89% | 18 |
|
|
2024
Q1 | $30.5M | Sell |
112,740
-5,000
| -4% | -$1.35M | 2.49% | 15 |
|
|
2023
Q4 | $27.8M | Buy |
117,740
+30,000
| +34% | +$7.09M | 2.33% | 16 |
|
|
2023
Q3 | $17.2M | Hold |
87,740
| – | – | 1.56% | 22 |
|
|
2023
Q2 | $18.4M | Hold |
87,740
| – | – | 1.6% | 21 |
|
|
2023
Q1 | $17.7M | Hold |
87,740
| – | – | 1.45% | 23 |
|
|
2022
Q4 | $19.1M | Sell |
87,740
-18,000
| -17% | -$3.92M | 1.7% | 21 |
|
|
2022
Q3 | $20.8M | Sell |
105,740
-39,000
| -27% | -$7.68M | 1.75% | 20 |
|
|
2022
Q2 | $31M | Buy |
144,740
+67,640
| +88% | +$14.5M | 1.92% | 24 |
|
|
2022
Q1 | $21.9M | Buy |
+77,100
| New | +$21.9M | 1.1% | 30 |
|
|
2021
Q3 | – | Sell |
-124,000
| Closed | -$45.9M | – | 58 |
|
|
2021
Q2 | $45.9M | Sell |
124,000
-39,000
| -24% | -$14.4M | 1.89% | 22 |
|
|
2021
Q1 | $47.2M | Sell |
163,000
-14,000
| -8% | -$4.06M | 2% | 20 |
|
|
2020
Q4 | $44.2M | Sell |
177,000
-21,000
| -11% | -$5.25M | 2.07% | 20 |
|
|
2020
Q3 | $44.8M | Sell |
198,000
-27,000
| -12% | -$6.11M | 2.16% | 18 |
|
|
2020
Q2 | $39.2M | Buy |
+225,000
| New | +$39.2M | 1.69% | 22 |
|